Both the EU and the FDA aim to ensure that pharmaceutical products meet the highest standards of quality, safety, and efficacy, thereby protecting public health. However, there are some differences in their regulatory frameworks, focus areas, and inspection processes.
Such as, EU strongly emphasis on quality risk management (ICH Q9) and quality systems but FDA strongly focus on data integrity, process validation, and compliance history.